Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Prepaid Assets (2023 - 2025)

Historic Prepaid Assets for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $13.5 million.

  • CG Oncology's Prepaid Assets rose 2027.95% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 2027.95%. This contributed to the annual value of $12.2 million for FY2024, which is 9207.3% up from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Prepaid Assets is $13.5 million, which was up 2027.95% from $11.4 million recorded in Q2 2025.
  • CG Oncology's 5-year Prepaid Assets high stood at $13.5 million for Q3 2025, and its period low was $6.4 million during Q4 2023.
  • Its 3-year average for Prepaid Assets is $11.2 million, with a median of $11.7 million in 2024.
  • As far as peak fluctuations go, CG Oncology's Prepaid Assets skyrocketed by 9207.3% in 2024, and later soared by 388.32% in 2025.
  • Over the past 3 years, CG Oncology's Prepaid Assets (Quarter) stood at $6.4 million in 2023, then skyrocketed by 92.07% to $12.2 million in 2024, then rose by 10.64% to $13.5 million in 2025.
  • Its Prepaid Assets was $13.5 million in Q3 2025, compared to $11.4 million in Q2 2025 and $12.4 million in Q1 2025.